Skip to main content
. 2023 Oct 2;23:646. doi: 10.1186/s12879-023-08538-9

Table 3.

Multivariable Cox model for hospital admission or death among non-complicated COVID-19 patients treated with early antiviral treatment

HRadj (95% CI)a p-value
Vaccination
No Reference
Yes 0.31 (0.14–0.70) 0.005
Covid-19 severity
Mild Reference
Moderate 12.23 (4.65–32.18) < 0.001
Time from symptoms onset to treatment (days) b (with time-varying HR) c
0–1 Reference
2 0.22 (0.05–1.11) 0.068
3 0.51 (0.04-6.00) 0.593
More than 4 0.09 (0.01–0.66) 0.019

aSurvey-weighted Cox regression model with inverse-probability weighting and design-based standard errors. HRadj: Hazard Ratio adjusted for sex

bCategories are based on quartiles

cTime-varying HR (HRtv) was calculated using: HRtv=exp [β1X + β2Xlog(t)] = HR(X)*exp[β2Xlog(t)]. For each category of time from symtpoms onset to treatment, we considered:

-category “2 days”: β1= -1.50, β2 = 0.70, HR = 0.22

HRtv=exp[-1.50 + 0.70*log(t)] = 0.22*exp[0.70*log(t)]

-category “3 days”: β1= -0.67, β2 = 0.54, HR = 0.51

HRtv=exp[-0.67 + 0.54*log(t)] = 0.51*exp[0.54*log(t)]

-category “More than 4 days”: β1= -1.18, β2 = 0.08, HR = 0.09

HRtv=exp[-1.18 + 0.08*log(t)] = 0.09*exp[0.08*log(t)]

The plot of these HRtv is reported in Fig. 2